NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000028184

Registered date:15/07/2017

The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedWe invited patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma
Date of first enrollment2005/10/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)administration of GHRP-2

Outcome(s)

Primary OutcomeSerum TSH, GH and prolactin levels after administration of GHRP-2
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum15years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaAllergy to GHRP-2

Related Information

Contact

public contact
Name Kazunori Kageyama
Address 5 Zaifu-cho, Hirosaki, Aomori, Japan Japan
Telephone 0172-39-5062
E-mail kageyama@hirosaki-u.ac.jp
Affiliation Hirosaki University Graduate School of Medicine Depertment of Endocrinology and Metabolism
scientific contact
Name Kazunori Kageyama
Address 5 Zaifu-cho, Hirosaki, Aomori, Japan Japan
Telephone 0172-39-5062
E-mail kageyama@hirosaki-u.ac.jp
Affiliation Hirosaki University Graduate School of Medicine Depertment of Endocrinology and Metabolism